Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 42 Lymphoma 31 Lymphoma, Large B-Cell, Diffuse 27 Osteosarcoma 20 Lymphoma, Non-Hodgkin 18 Hodgkin Disease 17 Testicular Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Ovarian Neoplasms 11 Burkitt Lymphoma 11 Testicular Germ Cell Tumor 10 Neuroectodermal Tumors, Primitive, Peripheral 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Follicular 8 Teratoma 7 Recurrence 7 Lymphoma, Large-Cell, Anaplastic 7 Leukemia 7 Central Nervous System Neoplasms 7 Neuroblastoma 6 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell 6 Breast Neoplasms 6 Seminoma 5 Neoplasms, Germ Cell and Embryonal 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Endodermal Sinus Tumor 5 Carcinoma, Non-Small-Cell Lung 5

Interventions

Diathermy 17 Radiotherapy 10 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Conization 2 spartalizumab 1 anlotinib 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡